Compass Therapeutics, Inc.
- CMPX
- NASDAQ
- Biotechnology
- Oncology/Antibody Therapeutics
- Cancer Immunotherapy
$0.85
Today +1.99%Quote Oct 20, 2026, 05:54 PM UTC
−56.05%over the last month
Max drawdown −56.1%From 1-month high −56.1%3 months −60.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Compass Therapeutics
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
39
Market value
$153.4M
Quote Oct 20
Floor
$0.83
3.1% below price
Resistance
$0.89
4.6% above price
Price vs analyst targets
17 analysts
Lowest target
$4.00Highest target
$6.00
$4.00Highest target
$6.00
- Price $0.85
- Average target $4.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 448% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CMPXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free